Get started
Cingulate Inc.Cingulate Inc.Cingulate Inc.

Cingulate Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

CING chart

Key stats

Market capitalization
‪3.10 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−30.3867USD
Net income
‪−23.53 M‬USD
Revenue
—
Shares float
‪3.42 M‬
Beta (1Y)
−1.46

About Cingulate Inc.

Sector
Health Technology
CEO
Shane J. Schaffer
Headquarters
Kansas City
Website
cingulate.com
Employees (FY)
13
Founded
2013
ISIN
US17248W2044
FIGI
BBG012G40MY2
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in 2013 and is headquartered in Kansas City, KS.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CING is 0.78 USD — it has decreased by 15.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cingulate Inc. stocks are traded under the ticker CING.
Cingulate Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
CING earnings for the last quarter are −6.00 USD whereas the estimation was −7.40 USD which accounts for 18.92% surprise. Estimated earnings for the next quarter are −4.86 USD. See more details about Cingulate Inc. earnings.
Yes, you can track Cingulate Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, CING shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cingulate Inc. stock right from TradingView charts — choose your broker and connect to your account.
CING reached its all-time high on Dec 8, 2021 with the price of 103.00 USD, and its all-time low was 0.92 USD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 13.00 employees. See our rating of the largest employees — is Cingulate Inc. on this list?